Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: MK.2206

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
MK.2206 AKT1/2/3 PI3K-AKT-mTOR signaling Phase 1, 2 Phase 2 Selleck Chemicals S1078

Cell Line (34)
Cell LineAUCGI50
JHH10.741.567
JHH50.762.15
B10.791.8
Mahlavu0.85.608
Huh10.814.383
HCC.1.10.813.923
HepaRG0.812.4
HCC.1.20.814.15
SNU3680.837.991
Huh70.844.3
MHCC97H0.842.435
HCC.30.862.9
SNU3870.877.05
SNU1820.886.266
JHH70.884.277


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it